Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma 113Leukemia 80Precursor Cell Lymphoblastic Leukemia-Lymphoma 61Lymphoma, Non-Hodgkin 59Multiple Myeloma 56Leukemia, Myeloid, Acute 56Lymphoma, Large B-Cell, Diffuse 55Hodgkin Disease 48Myelodysplastic Syndromes 43Burkitt Lymphoma 43Lymphoma, Follicular 41Leukemia, Lymphocytic, Chronic, B-Cell 41Lymphoma, Mantle-Cell 40Breast Neoplasms 35Lymphoma, Large-Cell, Immunoblastic 34Sarcoma 27Neoplasms, Plasma Cell 27Central Nervous System Neoplasms 25Lymphoma, B-Cell, Marginal Zone 24Dendritic Cell Sarcoma, Interdigitating 19Recurrence 18Leukemia, Myelogenous, Chronic, BCR-ABL Positive 18Ovarian Neoplasms 16Neuroblastoma 16Myeloproliferative Disorders 16Leukemia, Myeloid, Chronic-Phase 16Leukemia, Myeloid, Accelerated Phase 15Congenital Abnormalities 15Neutropenia 13Lung Neoplasms 13

Interventions

Octreotide 2telotristat ethyl 1isatuximab 1ceterizine hydrochloride 1capivasertib 1cabazitaxel 1XRP6258 1Prednisone 1Loperamide 1Leucovorin 1Lapatinib 1Irinotecan 1Injections 1Granulocyte Colony-Stimulating Factor 1Fulvestrant 1Fluorouracil 1Filgrastim 1Drugs, Investigational 1Cyclophosphamide 1Colesevelam Hydrochloride 1Cell- and Tissue-Based Therapy 1Capecitabine 1Calcium Aluminosilicate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Diarrhea × Filgrastim × Clear all
NCT00258180 2019-04-16

Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy

Johns Hopkins University

Phase 2 Completed
3 enrolled 5 charts

Diarrhea

Data powered by HemOnc (CC BY 4.0) Colophon âš¡